Concepedia

Author

Françoise Mazingue

Hôpital Robert-Debré

Also Known As

Christian Massot, Cyril Clavel, F Mazingue, F. Mazingue, Francoise Mazingue, Françoise Mazingue, Françoise Mazingue, Guilhem Sole, J Tricoire, Véronique Walter

157

Publications

4.5K

Citations

34

H-Index

111

Concepts

All Affiliations

Hôpital Robert-DebréInsermUniversité Paris CitéAssistance Publique – Hôpitaux de ParisEuropean Organisation for Research and Treatment of Cancer
FM

About

Françoise Mazingue is an author at Hôpital Robert-Debré specializing in medicine, pediatrics, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

22

1.4K

2

Health Sciences

7

7

276

3

Public Health

3

3

113

4

Social Sciences

1

1

38

5

Allergy

1

1

73

Françoise Mazingue

×

58

Publications

3.8K

Citations

32

H-Index

YearCitations

<i>BRAF</i> Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy

Sébastien Heritier, Jean‐François Emile, Mohamed‐Aziz Barkaoui,

Journal of Clinical Oncology

2016

327

Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

Alain Fischer, Johan Provot, Jean-Philippe Jaı̈s,

Journal of Allergy and Clinical Immunology

2017

304

Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

Marie‐Louise Frémond, Alice Hadchouel, Laureline Berteloot,

The Journal of Allergy and Clinical Immunology In Practice

2020

197

Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial

Frédéric Millot, André Baruchel, Joëlle Guilhot,

Journal of Clinical Oncology

2011

163

High WT1 Expression After Induction Therapy Predicts High Risk of Relapse and Death in Pediatric Acute Myeloid Leukemia

Hélène Lapillonne, Aline Renneville, Anne Auvrignon,

Journal of Clinical Oncology

2006

162

<scp>l</scp>‐asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005‐01 randomized trial

Carine Domenech, Xavier Thomas, Sylvie Chabaud,

British Journal of Haematology

2011

130

NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951

Emmanuelle Clappier, Sandra Collette, Nathalie Grardel,

Leukemia

2010

127

Is Intrapartum Intravenous Zidovudine for Prevention of Mother-to-Child HIV-1 Transmission Still Useful in the Combination Antiretroviral Therapy Era?

Nelly Briand, Josiane Warszawski, Laurent Mandelbrot,

Clinical Infectious Diseases

2013

126

Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond–like syndrome

Christine Bellanné‐Chantelot, Barbara Schmaltz-Panneau, Caroline Marty,

Blood

2018

116

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951

Emmanuelle Clappier, Nathalie Grardel, Marleen Bâkkus,

Leukemia

2015

103

Page 1